| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.939 | 0.002 | 0.939 | Psychostimulant | 0.881 0.003 CID_1411 | ||
| 0.858 | 0.002 | 0.858 | TRPA1 agonist | 0.734 0.002 CID_1411 | ||
| 0.829 | 0.002 | 0.829 | Cannabinoid CB2 receptor antagonist | 0.745 0.002 CID_1411 | ||
| 0.824 | 0.011 | 0.824 | Transcription factor NF kappa B inhibitor | 0.708 0.019 CID_1411 | ||
| 0.776 | 0.014 | 0.776 | Caspase 9 stimulant | 0.492 0.063 CID_1411 | ||
| 0.756 | 0.022 | 0.756 | Apoptosis agonist | 0.591 0.051 CID_1411 | ||
| 0.618 | 0.003 | 0.618 | Cannabinoid receptor antagonist | 0.515 0.003 CID_1411 | ||
| 0.651 | 0.041 | 0.651 | Antiinflammatory | 0.629 0.046 CID_1411 | ||
| 0.59 | 0.003 | 0.59 | Neurotrophic factor | 0.424 0.004 CID_1411 | ||
| 0.567 | 0.005 | 0.567 | Melanin inhibitor | 0.369 0.014 CID_1411 | ||
| 0.553 | 0.003 | 0.553 | Cannabinoid CB1 receptor antagonist | 0.451 0.003 CID_1411 | ||
| 0.551 | 0.015 | 0.551 | Antioxidant | 0.517 0.018 CID_1411 | ||
| 0.53 | 0.017 | 0.53 | Apoptosis antagonist | 0.352 0.055 CID_1411 | ||
| 0.503 | 0.022 | 0.613 | Spasmolytic | 0.613 0.012 CID_1411 | CID_1411 | |
| 0.495 | 0.021 | 0.495 | Caspase 3 stimulant | 0.353 0.058 CID_1411 | ||
| 0.472 | 0.005 | 0.472 | Protein kinase stimulant | 0.357 0.011 CID_1411 | ||
| 0.429 | 0.01 | 0.429 | Monophenol monooxygenase inhibitor | 0.374 0.013 CID_1411 | ||
| 0.458 | 0.039 | 0.691 | Cholesterol antagonist | 0.691 0.009 CID_1411 | CID_1411 | |
| 0.423 | 0.009 | 0.423 | Lipid peroxidase inhibitor | 0.391 0.01 CID_1411 | ||
| 0.419 | 0.005 | 0.419 | Neurotrophic factor enhancer | 0.308 0.016 CID_1411 | ||
| 0.425 | 0.032 | 0.475 | Lipoxygenase inhibitor | 0.475 0.022 CID_1411 | CID_1411 | |
| 0.413 | 0.027 | 0.415 | Free radical scavenger | 0.415 0.026 CID_1411 | CID_1411 | |
| 0.339 | 0.004 | 0.339 | Estrogen receptor alpha antagonist | 0.135 0.014 CID_1411 | ||
| 0.35 | 0.021 | 0.415 | P-glycoprotein inhibitor | 0.415 0.014 CID_1411 | CID_1411 | |
| 0.402 | 0.076 | 0.44 | Antibacterial | 0.44 0.06 CID_1411 | CID_1411 | |
| 0.342 | 0.033 | 0.342 | Nitric oxide antagonist | 0.322 0.036 CID_1411 | ||
| 0.358 | 0.062 | 0.381 | Immunostimulant | 0.381 0.055 CID_1411 | CID_1411 | |
| 0.315 | 0.026 | 0.315 | Hepatoprotectant | 0.309 0.027 CID_1411 | ||
| 0.336 | 0.05 | 0.384 | Hypoxia-inducible factor 1 alpha inhibitor | 0.384 0.034 CID_1411 | CID_1411 | |
| 0.362 | 0.093 | 0.362 | 15-Lipoxygenase inhibitor | 0.301 0.131 CID_1411 | ||
| 0.282 | 0.013 | 0.343 | DNA polymerase I inhibitor | 0.343 0.008 CID_1411 | CID_1411 | |
| 0.267 | 0.026 | 0.339 | Protein-tyrosine phosphatase inhibitor | 0.339 0.013 CID_1411 | CID_1411 | |
| 0.233 | 0.002 | 0.233 | Anabolic | 0.221 0.003 CID_1411 | ||
| 0.226 | 0.005 | 0.348 | Cannabinoid CB1 receptor agonist | 0.348 0.003 CID_1411 | CID_1411 | |
| 0.239 | 0.019 | 0.307 | Protein-tyrosine phosphatase 1B inhibitor | 0.307 0.01 CID_1411 | CID_1411 | |
| 0.224 | 0.007 | 0.224 | Aromatase inhibitor | 0.081 0.027 CID_1411 | ||
| 0.272 | 0.075 | 0.272 | Aldehyde oxidase inhibitor | 0.174 0.12 CID_1411 | ||
| 0.23 | 0.041 | 0.23 | Growth factor agonist | 0.187 0.077 CID_1411 | ||
| 0.282 | 0.096 | 0.35 | Sodium/bile acid cotransporter inhibitor | 0.35 0.04 CID_1411 | CID_1411 | |
| 0.219 | 0.034 | 0.219 | Phospholipase C inhibitor | 0.202 0.043 CID_1411 | ||
| 0.194 | 0.01 | 0.201 | Prolactin inhibitor | 0.201 0.009 CID_1411 | CID_1411 | |
| 0.198 | 0.013 | 0.198 | Estrogen antagonist | 0.152 0.023 CID_1411 | ||
| 0.25 | 0.067 | 0.279 | Hypolipemic | 0.279 0.056 CID_1411 | CID_1411 | |
| 0.214 | 0.048 | 0.28 | Lipocortins synthesis antagonist | 0.28 0.025 CID_1411 | CID_1411 | |
| 0.226 | 0.061 | 0.226 | Anesthetic general | 0.145 0.119 CID_1411 | ||
| 0.17 | 0.007 | 0.232 | Ornithine decarboxylase inhibitor | 0.232 0.004 CID_1411 | CID_1411 | |
| 0.191 | 0.029 | 0.325 | Cholesterol synthesis inhibitor | 0.325 0.009 CID_1411 | CID_1411 | |
| 0.202 | 0.04 | 0.216 | Interferon gamma antagonist | 0.216 0.036 CID_1411 | CID_1411 | |
| 0.17 | 0.012 | 0.17 | Estrogen receptor beta antagonist | 0.129 0.024 CID_1411 | ||
| 0.239 | 0.083 | 0.379 | Hypoglycemic | 0.379 0.031 CID_1411 | CID_1411 | |
| 0.294 | 0.146 | 0.47 | Analgesic | 0.47 0.058 CID_1411 | CID_1411 | |
| 0.154 | 0.007 | 0.154 | Estrogen receptor beta agonist | 0.123 0.009 CID_1411 | ||
| 0.161 | 0.014 | 0.161 | Thioredoxin inhibitor | 0.124 0.028 CID_1411 | ||
| 0.16 | 0.016 | 0.166 | Electron transport complex I inhibitor | 0.166 0.014 CID_1411 | CID_1411 | |
| 0.162 | 0.028 | 0.162 | Antineoplastic antibiotic | 0.105 0.044 CID_1411 | ||
| 0.254 | 0.13 | 0.351 | Vasodilator, coronary | 0.351 0.055 CID_1411 | CID_1411 | |
| 0.156 | 0.033 | 0.168 | Vanilloid 1 agonist | 0.168 0.025 CID_1411 | CID_1411 | |
| 0.134 | 0.013 | 0.134 | Estrogen agonist | 0.105 0.016 CID_1411 | ||
| 0.135 | 0.016 | 0.217 | Cannabinoid receptor agonist | 0.217 0.007 CID_1411 | CID_1411 | |
| 0.16 | 0.042 | 0.16 | Alkylator | 0.143 0.05 CID_1411 | ||
| 0.172 | 0.058 | 0.234 | Phospholipase A2 inhibitor | 0.234 0.028 CID_1411 | CID_1411 | |
| 0.206 | 0.1 | 0.26 | Vasodilator | 0.26 0.064 CID_1411 | CID_1411 | |
| 0.238 | 0.133 | 0.292 | Interleukin 2 agonist | 0.292 0.079 CID_1411 | CID_1411 | |
| 0.119 | 0.018 | 0.127 | Lipase inhibitor | 0.127 0.015 CID_1411 | CID_1411 | |
| 0.249 | 0.149 | 0.355 | Immunosuppressant | 0.355 0.084 CID_1411 | CID_1411 | |
| 0.116 | 0.019 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.103 0.029 CID_1411 | ||
| 0.192 | 0.107 | 0.319 | Platelet antagonist | 0.319 0.047 CID_1411 | CID_1411 | |
| 0.162 | 0.078 | 0.184 | Growth hormone agonist | 0.184 0.066 CID_1411 | CID_1411 | |
| 0.202 | 0.12 | 0.202 | DNA synthesis inhibitor | 0.201 0.121 CID_1411 | ||
| 0.091 | 0.01 | 0.091 | Estrogen receptor alpha agonist | 0.081 0.012 CID_1411 | ||
| 0.139 | 0.06 | 0.139 | Toll-Like receptor 2 antagonist | |||
| 0.157 | 0.079 | 0.177 | Interleukin 6 antagonist | 0.177 0.057 CID_1411 | CID_1411 | |
| 0.114 | 0.037 | 0.114 | Androgen antagonist | 0.088 0.057 CID_1411 | ||
| 0.142 | 0.076 | 0.156 | Adenylate cyclase stimulant | 0.156 0.054 CID_1411 | CID_1411 | |
| 0.094 | 0.031 | 0.114 | CDC25A inhibitor | 0.114 0.021 CID_1411 | CID_1411 | |
| 0.085 | 0.024 | 0.128 | Cannabinoid CB2 receptor agonist | 0.128 0.013 CID_1411 | CID_1411 | |
| 0.083 | 0.023 | 0.083 | TRPA1 antagonist | |||
| 0.075 | 0.019 | 0.075 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.132 | 0.078 | 0.172 | Farnesoid X receptor antagonist | 0.172 0.034 CID_1411 | CID_1411 | |
| 0.186 | 0.134 | 0.203 | 5 Hydroxytryptamine release stimulant | 0.203 0.118 CID_1411 | CID_1411 | |
| 0.107 | 0.056 | 0.118 | Bronchodilator | 0.118 0.046 CID_1411 | CID_1411 | |
| 0.073 | 0.023 | 0.073 | Alpha tubulin antagonist | |||
| 0.064 | 0.015 | 0.135 | 5-Alpha-reductase inhibitor | 0.135 0.008 CID_1411 | CID_1411 | |
| 0.105 | 0.056 | 0.121 | Xanthine oxidase inhibitor | 0.121 0.047 CID_1411 | CID_1411 | |
| 0.065 | 0.02 | 0.065 | Pregnane X receptor antagonist | |||
| 0.122 | 0.077 | 0.122 | Papain-like protease (SARS coronavirus) inhibitor | 0.118 0.086 CID_1411 | ||
| 0.142 | 0.098 | 0.172 | Mcl-1 antagonist | 0.172 0.072 CID_1411 | CID_1411 | |
| 0.253 | 0.209 | 0.365 | Cyclophilin D inhibitor | 0.365 0.112 CID_1411 | CID_1411 | |
| 0.063 | 0.02 | 0.063 | Vanilloid 2 antagonist | 0.062 0.02 CID_1411 | ||
| 0.134 | 0.091 | 0.181 | NOS3 expression enhancer | 0.181 0.049 CID_1411 | CID_1411 | |
| 0.124 | 0.082 | 0.124 | Bone formation stimulant | 0.12 0.085 CID_1411 | ||
| 0.161 | 0.119 | 0.194 | Insulin sensitizer | 0.194 0.079 CID_1411 | CID_1411 | |
| 0.044 | 0.004 | 0.046 | Toll-Like receptor 4 agonist | 0.046 0.004 CID_1411 | CID_1411 | |
| 0.176 | 0.139 | 0.176 | DNA damaging | 0.171 0.143 CID_1411 | ||
| 0.134 | 0.098 | 0.162 | Ca2+-transporting ATPase inhibitor | 0.162 0.021 CID_1411 | CID_1411 | |
| 0.053 | 0.017 | 0.053 | Dopamine D3 agonist | |||
| 0.1 | 0.064 | 0.133 | 5-Lipoxygenase inhibitor | 0.133 0.044 CID_1411 | CID_1411 | |
| 0.077 | 0.042 | 0.142 | Glycine receptor agonist | 0.142 0.008 CID_1411 | CID_1411 | |
| 0.255 | 0.221 | 0.498 | 5 Hydroxytryptamine release inhibitor | 0.498 0.033 CID_1411 | CID_1411 | |
| 0.058 | 0.026 | 0.058 | Glucose-6-phosphate translocase inhibitor | |||
| 0.054 | 0.022 | 0.054 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.036 | 0.005 | 0.055 | Vanilloid 2 agonist | 0.055 0.003 CID_1411 | CID_1411 | |
| 0.138 | 0.108 | 0.163 | Dual specificity phosphatase inhibitor | 0.163 0.081 CID_1411 | CID_1411 | |
| 0.031 | 0.003 | 0.031 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.145 | 0.121 | 0.373 | Non-steroidal antiinflammatory agent | 0.373 0.017 CID_1411 | CID_1411 | |
| 0.077 | 0.054 | 0.077 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.042 | 0.019 | 0.042 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.104 | 0.082 | 0.154 | Topoisomerase II inhibitor | 0.154 0.048 CID_1411 | CID_1411 | |
| 0.067 | 0.045 | 0.067 | Bcl2 antagonist | |||
| 0.199 | 0.177 | 0.421 | Vasodilator, peripheral | 0.421 0.049 CID_1411 | CID_1411 | |
| 0.037 | 0.016 | 0.039 | Calcium-independent phospholipase A2 inhibitor | 0.039 0.011 CID_1411 | CID_1411 | |
| 0.083 | 0.063 | 0.09 | Vanilloid agonist | 0.09 0.047 CID_1411 | CID_1411 | |
| 0.198 | 0.18 | 0.379 | Antithrombotic | 0.379 0.055 CID_1411 | CID_1411 | |
| 0.091 | 0.079 | 0.095 | Expectorant | 0.095 0.075 CID_1411 | CID_1411 | |
| 0.024 | 0.013 | 0.024 | Estrone sulfatase inhibitor | 0.022 0.015 CID_1411 | ||
| 0.188 | 0.177 | 0.28 | 5 Hydroxytryptamine uptake stimulant | 0.28 0.057 CID_1411 | CID_1411 | |
| 0.035 | 0.026 | 0.085 | Nicotinic acid receptor 2 agonist | 0.085 0.007 CID_1411 | CID_1411 | |
| 0.126 | 0.118 | 0.169 | Arachidonic acid antagonist | 0.169 0.066 CID_1411 | CID_1411 | |
| 0.022 | 0.017 | 0.029 | Prostaglandin F2 alpha agonist | 0.029 0.009 CID_1411 | CID_1411 | |
| 0.098 | 0.093 | 0.132 | Photosensitizer | 0.132 0.045 CID_1411 | CID_1411 | |
| 0.068 | 0.064 | 0.091 | GABA aminotransferase inhibitor | 0.091 0.035 CID_1411 | CID_1411 | |
| 0.018 | 0.015 | 0.053 | 5-Alpha-reductase 2 inhibitor | 0.053 0.007 CID_1411 | CID_1411 | |
| 0.106 | 0.105 | 0.106 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.086 | 0.086 | 0.109 | Phosphodiesterase 6D inhibitor | 0.109 0.037 CID_1411 | CID_1411 | |
| 0.089 | 0.09 | 0.184 | Cystathionine beta-synthase inhibitor | 0.184 0.029 CID_1411 | CID_1411 | |
| 0.013 | 0.014 | 0.015 | Prostacyclin agonist | 0.015 0.012 CID_1411 | CID_1411 | |
| 0.04 | 0.046 | 0.056 | Thromboxane A2 antagonist | 0.056 0.032 CID_1411 | CID_1411 | |
| 0.026 | 0.034 | 0.048 | ATP citrate lysase inhibitor | 0.048 0.008 CID_1411 | CID_1411 | |
| 0.054 | 0.063 | 0.094 | Peroxisome proliferator-activated receptor gamma agonist | 0.094 0.031 CID_1411 | CID_1411 | |
| 0.059 | 0.07 | 0.1 | Glutamate (mGluR6) antagonist | 0.1 0.01 CID_1411 | CID_1411 | |
| 0.031 | 0.043 | 0.063 | Retinoid X receptor antagonist | 0.063 0.005 CID_1411 | CID_1411 | |
| 0.053 | 0.064 | 0.059 | CDC25B inhibitor | 0.059 0.052 CID_1411 | CID_1411 | |
| 0.118 | 0.132 | 0.144 | Dual specificity phosphatase 3 inhibitor | 0.144 0.101 CID_1411 | CID_1411 | |
| 0.04 | 0.054 | 0.057 | Thromboxane antagonist | 0.057 0.034 CID_1411 | CID_1411 | |
| 0.009 | 0.031 | 0.019 | 5-Alpha-reductase 1 inhibitor | 0.019 0.011 CID_1411 | CID_1411 | |
| 0.048 | 0.071 | 0.093 | Leukotriene antagonist | 0.093 0.025 CID_1411 | CID_1411 | |
| 0.014 | 0.038 | 0.02 | Leukotriene B4 receptor 2 antagonist | 0.02 0.018 CID_1411 | CID_1411 | |
| 0.019 | 0.046 | 0.032 | Prostaglandin D2 agonist | 0.032 0.02 CID_1411 | CID_1411 | |
| 0.049 | 0.079 | 0.059 | Lipocortins synthesis agonist | 0.059 0.038 CID_1411 | CID_1411 | |
| 0.021 | 0.052 | 0.057 | Nicotinic acid receptor agonist | 0.057 0.012 CID_1411 | CID_1411 | |
| 0.084 | 0.116 | 0.144 | DOPA decarboxylase inhibitor | 0.144 0.025 CID_1411 | CID_1411 | |
| 0.134 | 0.167 | 0.193 | Antiamyloidogenic | 0.193 0.104 CID_1411 | CID_1411 | |
| 0.018 | 0.052 | 0.084 | Retinoid X receptor agonist | 0.084 0.007 CID_1411 | CID_1411 | |
| 0.013 | 0.05 | 0.026 | Leukotriene B4 receptor 1 antagonist | 0.026 0.021 CID_1411 | CID_1411 | |
| 0.024 | 0.061 | 0.048 | Retinoid X alpha receptor antagonist | 0.048 0.008 CID_1411 | CID_1411 | |
| 0.014 | 0.054 | 0.032 | Retinoic acid receptor agonist | 0.032 0.009 CID_1411 | CID_1411 | |
| 0.071 | 0.112 | 0.111 | ABCA1 expression enhancer | 0.111 0.038 CID_1411 | CID_1411 | |
| 0.016 | 0.058 | 0.038 | Prostaglandin agonist | 0.038 0.015 CID_1411 | CID_1411 | |
| 0.059 | 0.102 | 0.084 | Glycine receptor antagonist | 0.084 0.051 CID_1411 | CID_1411 | |
| 0.066 | 0.109 | 0.097 | Alcohol dehydrogenase inhibitor | 0.097 0.056 CID_1411 | CID_1411 | |
| 0.056 | 0.106 | 0.135 | Keratolytic | 0.135 0.017 CID_1411 | CID_1411 | |
| 0.035 | 0.089 | 0.057 | Leukotriene B4 antagonist | 0.057 0.031 CID_1411 | CID_1411 | |
| 0.162 | 0.22 | 0.188 | Tyrosine 3 hydroxylase inhibitor | 0.188 0.159 CID_1411 | CID_1411 | |
| 0.03 | 0.089 | 0.058 | Maillard reaction inhibitor | 0.058 0.036 CID_1411 | CID_1411 | |
| 0.097 | 0.162 | 0.177 | Angiogenesis stimulant | 0.177 0.107 CID_1411 | CID_1411 | |
| 0.035 | 0.107 | 0.081 | Thromboxane synthase inhibitor | 0.081 0.011 CID_1411 | CID_1411 | |
| 0.011 | 0.083 | 0.021 | Retinoic acid beta receptor agonist | 0.021 0.011 CID_1411 | CID_1411 | |
| 0.013 | 0.086 | 0.023 | Retinoic acid gamma receptor agonist | 0.023 0.013 CID_1411 | CID_1411 | |
| 0.019 | 0.092 | 0.06 | Peroxisome proliferator-activated receptor alpha agonist | 0.06 0.026 CID_1411 | CID_1411 | |
| 0.041 | 0.116 | 0.202 | Neuraminidase (influenza) inhibitor | 0.202 0.005 CID_1411 | CID_1411 | |
| 0.098 | 0.179 | 0.18 | Platelet adhesion inhibitor | 0.18 0.082 CID_1411 | CID_1411 | |
| 0.082 | 0.165 | 0.116 | Peroxidase inhibitor | 0.116 0.104 CID_1411 | CID_1411 | |
| 0.042 | 0.127 | 0.06 | Leukotriene C antagonist | 0.06 0.029 CID_1411 | CID_1411 | |
| 0.021 | 0.107 | 0.049 | Retinoic acid alpha receptor agonist | 0.049 0.015 CID_1411 | CID_1411 | |
| 0.062 | 0.149 | 0.114 | Bile acid receptor antagonist | 0.114 0.026 CID_1411 | CID_1411 | |
| 0.124 | 0.214 | 0.182 | Cardiotonic | 0.182 0.138 CID_1411 | CID_1411 | |
| 0.164 | 0.254 | 0.262 | Antiobesity | 0.262 0.145 CID_1411 | CID_1411 | |
| 0.027 | 0.12 | 0.039 | Leukotriene C4 antagonist | 0.039 0.027 CID_1411 | CID_1411 | |
| 0.026 | 0.12 | 0.2 | Neuraminidase inhibitor | 0.2 0.004 CID_1411 | CID_1411 | |
| 0.023 | 0.121 | 0.088 | Neuraminidase (Influenza A) inhibitor | 0.088 0.004 CID_1411 | CID_1411 | |
| 0.007 | 0.106 | 0.018 | Retinoic acid alpha receptor antagonist | 0.018 0.017 CID_1411 | CID_1411 | |
| 0.022 | 0.127 | 0.036 | Glutamate (mGluR8) antagonist | 0.036 0.025 CID_1411 | CID_1411 | |
| 0.011 | 0.117 | 0.03 | Nicotinic acid receptor 2 antagonist | 0.03 0.013 CID_1411 | CID_1411 | |
| 0.108 | 0.215 | 0.167 | Succinate dehydrogenase inhibitor | 0.167 0.084 CID_1411 | CID_1411 | |
| 0.028 | 0.139 | 0.08 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.08 0.025 CID_1411 | CID_1411 | |
| 0.062 | 0.174 | 0.093 | Interleukin 1b antagonist | 0.093 0.09 CID_1411 | CID_1411 | |
| 0.05 | 0.171 | 0.097 | Uric acid excretion stimulant | 0.097 0.056 CID_1411 | CID_1411 | |
| 0.071 | 0.194 | 0.127 | Interleukin 4 antagonist | 0.127 0.076 CID_1411 | CID_1411 | |
| 0.038 | 0.162 | 0.089 | NMDA receptor antagonist | 0.089 0.055 CID_1411 | CID_1411 | |
| 0.09 | 0.228 | 0.135 | Tumour necrosis factor antagonist | 0.135 0.12 CID_1411 | CID_1411 | |
| 0.149 | 0.289 | 0.433 | Histamine release inhibitor | 0.433 0.058 CID_1411 | CID_1411 | |
| 0.06 | 0.202 | 0.128 | Thrombolytic | 0.128 0.101 CID_1411 | CID_1411 | |
| 0.01 | 0.158 | 0.033 | Retinoid X alpha receptor agonist | 0.033 0.026 CID_1411 | CID_1411 | |
| 0.092 | 0.24 | 0.162 | Sphingosine 1-phosphate receptor 5 antagonist | 0.162 0.043 CID_1411 | CID_1411 | |
| 0.009 | 0.157 | 0.02 | Neuraminidase (Influenza B) inhibitor | 0.02 0.017 CID_1411 | CID_1411 | |
| 0.048 | 0.2 | 0.115 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.115 0.042 CID_1411 | CID_1411 | |
| 0.081 | 0.236 | 0.131 | Sphingosine 1-phosphate receptor 2 antagonist | 0.131 0.072 CID_1411 | CID_1411 | |
| 0.11 | 0.279 | 0.14 | Heat shock protein 70 antagonist | 0.14 0.075 CID_1411 | CID_1411 | |
| 0.013 | 0.184 | 0.052 | Prostaglandin EP2 antagonist | 0.052 0.049 CID_1411 | CID_1411 | |
| 0.053 | 0.265 | 0.103 | Cyclooxygenase 3 inhibitor | 0.103 0.099 CID_1411 | CID_1411 | |
| 0.038 | 0.27 | 0.108 | GABA C receptor antagonist | 0.108 0.067 CID_1411 | CID_1411 | |
| 0.046 | 0.297 | 0.088 | Carbonic anhydrase XV inhibitor | 0.088 0.087 CID_1411 | CID_1411 | |
| 0.028 | 0.319 | 0.056 | Adenine nucleotide translocase inhibitor | 0.056 0.037 CID_1411 | CID_1411 | |
| 0.138 | 0.433 | 0.262 | Calcium channel L-type activator | 0.262 0.193 CID_1411 | CID_1411 | |
| 0.054 | 0.35 | 0.187 | Interleukin agonist | 0.187 0.133 CID_1411 | CID_1411 | |
| 0.059 | 0.362 | 0.124 | Insulin secretagoues | 0.124 0.104 CID_1411 | CID_1411 | |
| 0.085 | 0.482 | 0.211 | Calcium channel activator | 0.211 0.198 CID_1411 | CID_1411 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |